Christabel Khaemba

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Breast Cancer Cells

Drug Administration

Top Venues

International journal of environmental research and public health

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Eugene P van Puijenbroek, Abbie Barry, Christabel Khaemba, Lazare Ntirenganya, Tigist Dires Gebreyesus, Adam Mitangu Fimbo, Omary M S Minzi, Eyasu Mekonnen Eshetu, Margaret N Oluka, Anastasia Guantai, Eleni Aklillu
Short-Term Training, a Useful Approach for Sustainable Pharmacovigilance Knowledge Development in Tanzania, Kenya, Ethiopia and Rwanda. Drug safety (2024)
Christabel Khaemba, Abbie Barry, Wyckliff Peter Omondi, Elvis Kirui, Margaret N Oluka, Parthasarathi Gurumurthy, Sammy M Njenga, Anastacia Guantai, Eleni Aklillu
Comparative Safety Surveillance of Triple (IDA) Versus Dual Therapy (DA) in Mass Drug Administration for Elimination of Lymphatic Filariasis in Kenya: A Cohort Event Monitoring Study. Drug safety (2023)
Abbie Barry, Sten Olsson, Christabel Khaemba, Joseph Kabatende, Tigist Dires, Adam Fimbo, Omary Minzi, Emile Bienvenu, Eyasu Mekonnen Eshetu, Appolinary Kamuhabwa, Margaret Oluka, Anastasia Guantai, Eugène van Puijenbroek, Ulf Bergman, Alex Nkayamba, Michael Mugisha, Parthasarathi Gurumurthy, Eleni Aklillu
Comparative Assessment of the Pharmacovigilance Systems within the Neglected Tropical Diseases Programs in East Africa-Ethiopia, Kenya, Rwanda, and Tanzania. International journal of environmental research and public health 18 (4) (2021)
Christabel Khaemba, Abbie Barry, Wyckliff Peter Omondi, Kefa Bota, Sultani Matendechero, Cecilia Wandera, Fred Siyoi, Elvis Kirui, Margaret Oluka, Pamela Nambwa, Parthasarathi Gurumurthy, Sammy M Njenga, Anastacia Guantai, Eleni Aklillu
Safety and Tolerability of Mass Diethylcarbamazine and Albendazole Administration for the Elimination of Lymphatic Filariasis in Kenya: An Active Surveillance Study. Pharmaceuticals (Basel, Switzerland) 14 (3) (2021)